Paper10124
Pharmacokinetics of oxprenolol in normal subjects.
Mason WD and 1 other. Clin Pharmacol Ther, 1976. Cited by 66 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pharmacokinetics of oxprenolol in normal subjects. Papers, record 10124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10124
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Oxprenolol | Major topic |
| Administration, Oral | |
| Adrenergic beta-Antagonists | |
| Adult | |
| Biological Availability | |
| Blood Pressure | |
| Female | |
| Humans | |
| Injections, Intravenous | |
| Kinetics | |
| Male | |
| Physical Exertion | |
| Pulse |
Source PubMed
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,735,694 | Estimating Human Jejunal Effective Permeability Using Numerical Deconvolution of Oral Solution Concentration Data. | Pharm Res | 2026 | https://conductscience.org/library/papers/41735694 | PubMed |
| 41,199,105 | An automated pipeline to generate initial estimates for population Pharmacokinetic base models. | J Pharmacokinet Pharmacodyn | 2025 | https://conductscience.org/library/papers/41199105 | PubMed |
| 34,112,223 | Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup. | Crit Care | 2021 | https://conductscience.org/library/papers/34112223 | PubMed |
| 17,372,687 | Mechanistic approaches to volume of distribution predictions: understanding the processes. | Pharm Res | 2007 | https://conductscience.org/library/papers/17372687 | PubMed |
| 9,725,478 | Relative bioavailability of different oral sustained release oxprenolol tablets. | Eur J Drug Metab Pharmacokinet | 1998 | https://conductscience.org/library/papers/9725478 | PubMed |
| 8,261,714 | Individual variation in first-pass metabolism. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8261714 | PubMed |
| 7,398,733 | Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7398733 | PubMed |
| 7,356,910 | Pharmacokinetics of acebutolol after intravenous bolus administration. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7356910 | PubMed |
| 7,175,699 | Pharmacokinetics of lidocaine and its deethylated metabolite: dose and time dependency studies in man. | J Pharmacokinet Biopharm | 1982 | https://conductscience.org/library/papers/7175699 | PubMed |
| 7,023,516 | Right ventricular performance in essential hypertension after beta-blockade. | Br Heart J | 1981 | https://conductscience.org/library/papers/7023516 | PubMed |
| 6,832,204 | Initiation and maintenance of beta-blockade with intravenous oxprenolol. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6832204 | PubMed |
| 6,487,485 | Oxprenolol placental transfer, plasma concentrations in newborns and passage into breast milk. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6487485 | PubMed |
| 6,362,950 | First-pass elimination. Basic concepts and clinical consequences. | Clin Pharmacokinet | 1984 | https://conductscience.org/library/papers/6362950 | PubMed |
| 6,150,103 | Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man. | J Pharmacokinet Biopharm | 1984 | https://conductscience.org/library/papers/6150103 | PubMed |
| 6,120,714 | Relationship between plasma beta-adrenoceptor blocker concentration and pharmacodynamic activity. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6120714 | PubMed |
| 4,005,132 | Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: design and evaluation of systems for once-daily administration. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4005132 | PubMed |
| 4,005,122 | Influence of food intake on plasma oxprenolol concentrations following oral administration of conventional and Oros preparations. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4005122 | PubMed |
| 4,005,119 | Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4005119 | PubMed |
| 4,005,118 | Pharmacokinetic investigation of the absorption of oxprenolol from Oros delivery systems in healthy volunteers: comparison of in vivo and in vitro drug release. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4005118 | PubMed |
| 4,005,117 | In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol Oros preparations. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4005117 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10124
GET https://conductscience.org/api/papers/v1/10124/cited_by?page=2